OSTEOGENESIS IMPERFECTA
Clinical trials for OSTEOGENESIS IMPERFECTA explained in plain language.
Never miss a new study
Get alerted when new OSTEOGENESIS IMPERFECTA trials appear
Sign up with your email to follow new studies for OSTEOGENESIS IMPERFECTA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could donor cells help kids with brittle bones grow taller and stronger?
Disease control Not yet recruitingThis early-stage study tests whether infusions of donor bone-marrow cells (mesenchymal stromal cells) are safe and can improve growth and bone health in 12 children aged 3–10 with severe Osteogenesis Imperfecta Type 3 (brittle bone disease). The treatment aims to reduce fractures…
Matched conditions: OSTEOGENESIS IMPERFECTA
Phase: PHASE1, PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New study aims to stop misdiagnosis of rare childhood joint disorders
Knowledge-focused Not yet recruitingThis study looks at children with joint problems that are not caused by inflammation, such as stiffness or deformity. The goal is to find the real underlying causes using exams, lab tests, and imaging. By doing this, doctors hope to avoid misdiagnosis and unnecessary treatments. …
Matched conditions: OSTEOGENESIS IMPERFECTA
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated May 17, 2026 02:35 UTC